Skip to content

Text Message for Adolescents With Poorly Controlled Type 1 Diabetes

Impact of Mobile Phone Short Text Messages on the Glycaemic Control of Adolescents With Poorly Controlled Type 1 Diabetes.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02230137
Acronym
DIABETO-SMS
Enrollment
92
Registered
2014-09-03
Start date
2015-02-01
Completion date
2016-07-01
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

adolescents, type 1 diabetes, poorly controlled, SMS, Improve glycaemic control, HbA1c reduction, poorly controlled type 1 diabetic adolescents

Brief summary

The purpose of this study is to assess HbA1c reduction after supportive care by SMS among adolescents with poorly controlled type 1 diabetes.

Detailed description

In 2010, the number of children with type 1 diabetes in France is estimated at 12,000 with 60% of them aged 12 to 17 years. Compliance is a major issue during adolescence. Mobile text message is one of the strategies to enhance adherence. The main aim of this study is to assess HbA1c reduction after a 6 month SMS support among adolescents with poorly controlled type 1 diabetes. Adherence and quality of life will also be assessed at the end of the trial. This study is a prospective randomized monocentric trial. Sixty adolescents with type 1 diabetes and HbA1c equal or higher than 8.5 % will be randomized according to the method of Zelen in two groups : standard treatment versus standard treatment plus support by SMS. The patients will receive one SMS before each injection of insulin.

Interventions

BEHAVIORALText message arm

Text message sent before each injection of insulin

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

* aged between 12 and 21 years old * with type 1 diabetes for more than 6 months * HbA1c at enrollment \> 8.5% * non-opposition of one of the parents * previous medical exam (art. L.1121-11 du CSP) * Possible follow-up for 6 months * social welfare coverage * Adolescents with a mobile phone, able to receive short text message

Exclusion criteria

* aged less than 12 or higher than 21 years old * with HbA1c at enrollment \< 8.5% * pregnancy * psychiatric disease * do not understand french

Design outcomes

Primary

MeasureTime frame
HbA1c level6 months

Secondary

MeasureTime frameDescription
HbA1c level3 months
Compliance3 monthsblood glucose level
Quality of life3 monthsPedsQL version 4.0
Satisfaction survey6 months7 items for patients randomized in the "Text message arm"

Countries

France

Contacts

STUDY_DIRECTORJean-Marc Tréluyer, MD, PhD

Assistance Publique - Hôpitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026